Scott Gottlieb, MD

Scott Gottlieb, MD

Scott Gottlieb, MD

Scott Gottlieb, MD is a practicing physician and Resident Fellow at the American Enterprise Institute. From 2005-2007, Dr. Gottlieb served as FDA Deputy Commissioner and before that, from 2003-2004, as a senior advisor to the FDA Commissioner and as the FDA’s Director of Medical Policy Development. He left FDA in the spring of 2004 to work on implementation of the new Medicare Drug Benefit as a Senior Adviser to the Administrator of Medicare and Medicaid Services, where he supported the agency’s work on quality improvement and coverage and payment decision-making, particularly related to new medical technologies. Dr. Gottlieb is a member of the Scientific Advisory Board of the Brain Health Institute at Rutgers University. He is a Director of Molecular Insights (MIPI) a radiotherapy and cancer diagnostics company; and CombiMatrix (CBMX) a medical diagnostics company focused on gene profiling and cancer diagnostics. Dr. Gottlieb is partner to a healthcare investment firm and continues to practice medicine as a hospitalist. He completed a residency in internal medicine at the Mount Sinai Hospital in New York City and is a graduate of the Mount Sinai School of Medicine and of Wesleyan University, in Middletown, Connecticut.

Connect With Us
Join other physicians who are receiving our updates.
We hate spam. Your email address will not be sold or shared with anyone else.